Neurogenx Working To Provide Greater Access To Needed Treatment
First Specialty Neurogenx Nerve Centers Open in Alabama and California To Improve Treatment Outcomes for Patients with Neuropathy and Chronic Nerve Conditions
LANSING, Mich., July 17, 2015 /PRNewswire/ -- In a milestone for both Neurogenx and neuropathy patients, the first two Neurogenx Nerve Centers in the country are scheduled to open this summer. The grand opening of the Hoover, Alabama Center is July 20 followed by the Palm Desert, California Center in August. The Nerve Centers are the heart of a coordinated effort to increase awareness of the seriousness of peripheral neuropathy and provide greater access to effective treatment.
Neuropathy is the tingling, burning, pain and numbness in feet and hands caused by nerve damage due to diabetes and chronic nerve conditions such as fibromyalgia and carpal tunnel syndrome. It affects nearly 30% of Americans over the age of 40. Traditionally difficult to treat, patients often go without relief for the painful symptoms. In worst-case diabetic scenarios, neuropathy can lead to loss of balance, falls and injuries that don't heal – perhaps even resulting in the amputation of a foot or leg.
"The Neurogenx Electronic Signal Technology treatment changes all that," said Paul Todd, Executive Director of the Neurogenx Center in Hoover. "We use a restorative medical protocol that helps the body heal itself." Todd was introduced to Neurogenx while working with podiatrists as part of his in-office dispensing business. He had been living with severe pain in one foot for more than six months following a swimming pool accident. He had visited numerous medical practitioners without relief, but after two Neurogenx treatments, Todd's foot pain vanished and has not returned. "I was convinced right then and there that I had to help make this treatment available to other people suffering with neuropathy."
Patented and FDA-cleared as the only device of its kind, the Neurogenx 4000Pro uses advanced Electronic Signal Technology (EST) in a non-surgical, non-narcotic treatment that resolves neuropathy symptoms in more than four out of five patients. It has been used by hundreds of physicians nationwide with dramatic results.
"Improvement often becomes noticeable within 3-4 treatments," said Keith London, President of the Neurogenx Nerve Center in Palm Desert. "And because so many neuropathy patients have been shuffled from doctor to doctor with no hope for a solution, we wanted the Neurogenx treatment experience to be entirely different," added London. "Our facilities are new, comfortable and attractive, designed to make a treatment feel more like a spa experience than a doctor visit."
Neurogenx Nerve Centers are staffed by specially-trained clinicians, certified in the Neurogenx treatment protocol. The Centers are independently owned and operated, but receive training, marketing and business support from Neurogenx corporate headquarters.
About Neurogenx:
Neurogenx is an independent medical device manufacturer committed to providing physicians with an effective treatment for peripheral neuropathy and chronic nerve conditions. Headquartered in Lansing, Michigan, Neurogenx designed and offers the Neurogenx 4000PRO, which uses cutting-edge Electronic Signal Technology (EST) to help peripheral neuropathy and resolve chronic nerve conditions.
SOURCE Neurogenx
Share this article